LIXTE Screenshot 1
Janet is a pleasure to work with. Superb attention to detail, congenial, proactive, collaborative, speedy turnaround time, and meticulous and creative design. For 15 years, we have relied on her expert eye to handle our graphic design projects. She has crafted a catchy logo, revamped our investor marketing materials and redesigned the company website. We highly recommend her and her work!
Eric J. Forman, J.D.

CAO, Lixte Biotechnology Holdings, Inc.

LIXTE Screenshot 2

LIXTE Screenshot 3


Lixte Biotechnology Holdings, Inc. (Lixte) a publicly traded (OTCQB: LIXT) drug discovery company, Lixte has a developed unique, proprietary, first in-class protein phosphatase inhibitor, LB-100, that has potential widespread use as an anti-cancer agent alone and in combination with standard anti-cancer cytotoxic drugs, radiation, and immune checkpoint blockers.

What We Did

The third version of LIXTE is now a responsive, mobile friendly WordPress website.